Genesis Fertility Center Public Company Limited

As of June 30, 2026, Genesis Fertility Center Public Company Limited carries a market capitalization of 510.40M, placing it among publicly traded companies globally. Its enterprise value stands at 457.96M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Genesis Fertility Center Public Company Limited's next confirmed earnings release is scheduled for November 16, 2026.

As of June 30, 2026, Genesis Fertility Center Public Company Limited has 220.00M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Genesis Fertility Center Public Company Limited maintains a current ratio of 2.76, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Genesis Fertility Center Public Company Limited recorded 758,198.29 in income tax expense.

As of the close on October 22, 2026, Genesis Fertility Center Public Company Limited's stock has declined approximately 35.03% over the past 52 weeks. The 50-day moving average sits at 2.14, while the 200-day moving average is 2.55.

As of June 30, 2026, Genesis Fertility Center Public Company Limited holds 98.28M in cash and equivalents against 24.90M in total debt, resulting in a net debt position of -98.28M. Total book value stands at 533.81M, with working capital of 77.33M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Genesis Fertility Center Public Company Limited paid dividends of 0.13 per share.